Reuters -- Abbott Laboratories on Tuesday said European regulators approved a new, more flexible version of its Xience drug-eluting stent that is designed for easier placement in the diseased coronary artery.
Reuters -- Abbott Laboratories on Tuesday said European regulators approved a new, more flexible version of its Xience drug-eluting stent that is designed for easier placement in the diseased coronary artery.
